Condensed Consolidated Statement of Stockholders Equity (Unaudited) - USD ($)	Chief Executive Officer [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Chief Executive Officer [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Chief Executive Officer [Member] Common Stock [Member]	Chief Executive Officer [Member] Additional Paid-in Capital [Member]	Chief Executive Officer [Member] Retained Earnings [Member]	Chief Executive Officer [Member]	Private Placement [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Private Placement [Member] Common Stock [Member]	Private Placement [Member] Additional Paid-in Capital [Member]	Private Placement [Member] Retained Earnings [Member]	Private Placement [Member]	May 2020 Offering [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	May 2020 Offering [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	May 2020 Offering [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	May 2020 Offering [Member] Common Stock [Member]	May 2020 Offering [Member] Additional Paid-in Capital [Member]	May 2020 Offering [Member] Retained Earnings [Member]	May 2020 Offering [Member]	Asset Purchase Agreement [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Asset Purchase Agreement [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Asset Purchase Agreement [Member] Common Stock [Member]	Asset Purchase Agreement [Member] Additional Paid-in Capital [Member]	Asset Purchase Agreement [Member] Retained Earnings [Member]	Asset Purchase Agreement [Member]	Bridge Notes [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Bridge Notes [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Bridge Notes [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Bridge Notes [Member] Common Stock [Member]	Bridge Notes [Member] Additional Paid-in Capital [Member]	Bridge Notes [Member] Retained Earnings [Member]	Bridge Notes [Member]	Warrants Issued to CEO [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Warrants Issued to CEO [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Warrants Issued to CEO [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Warrants Issued to CEO [Member] Common Stock [Member]	Warrants Issued to CEO [Member] Additional Paid-in Capital [Member]	Warrants Issued to CEO [Member] Retained Earnings [Member]	Warrants Issued to CEO [Member]	Warrants Held by Noteholders [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Warrants Held by Noteholders [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Warrants Held by Noteholders [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Warrants Held by Noteholders [Member] Common Stock [Member]	Warrants Held by Noteholders [Member] Additional Paid-in Capital [Member]	Warrants Held by Noteholders [Member] Retained Earnings [Member]	Warrants Held by Noteholders [Member]	Prefunded Warrant [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Prefunded Warrant [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Prefunded Warrant [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Prefunded Warrant [Member] Common Stock [Member]	Prefunded Warrant [Member] Additional Paid-in Capital [Member]	Prefunded Warrant [Member] Retained Earnings [Member]	Prefunded Warrant [Member]	Conversion of Series E Preferred Stock to Common Stock [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Conversion of Series E Preferred Stock to Common Stock [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Conversion of Series E Preferred Stock to Common Stock [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Conversion of Series E Preferred Stock to Common Stock [Member] Common Stock [Member]	Conversion of Series E Preferred Stock to Common Stock [Member] Additional Paid-in Capital [Member]	Conversion of Series E Preferred Stock to Common Stock [Member] Retained Earnings [Member]	Conversion of Series E Preferred Stock to Common Stock [Member]	Conversion of Series D Preferred Stock to Common Stock [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Conversion of Series D Preferred Stock to Common Stock [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Conversion of Series D Preferred Stock to Common Stock [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Conversion of Series D Preferred Stock to Common Stock [Member] Common Stock [Member]	Conversion of Series D Preferred Stock to Common Stock [Member] Additional Paid-in Capital [Member]	Conversion of Series D Preferred Stock to Common Stock [Member] Retained Earnings [Member]	Conversion of Series D Preferred Stock to Common Stock [Member]	Asset Purchase Agreement [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Director [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Director [Member] Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Director [Member] Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Director [Member] Common Stock [Member]	Director [Member] Additional Paid-in Capital [Member]	Director [Member] Retained Earnings [Member]	Director [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Preferred Stock [Member] Series E Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2018																																																																												79,246			1,409,175
Balance at Dec. 31, 2018																																																																												$ 792			$ 14,092	$ 63,146,533	$ (63,107,945)	$ 53,472
Shares issued pursuant to CEO exchange agreement			$ 78	$ 49,922		$ 50,000			$ 2,864	$ 2,426,845		$ 2,429,709
Shares issued pursuant to CEO exchange agreement (in shares)			7,813						286,375
Warrants issued pursuant to 2020 convertible debt																																					$ 318,058		$ 318,058
Shares issued pursuant to note conversions - bridge loan																													$ 160	$ 89,840		$ 90,000
Shares issued pursuant to note conversions - bridge loan (in shares)																													15,985
Vesting expense																																																																																263,600		263,600
Net loss																																																																																	(3,293,184)	(3,293,184)
Balance (in shares) at Mar. 31, 2019																																																																												79,246			1,736,015
Balance at Mar. 31, 2019																																																																												$ 792			$ 17,360	66,452,982	(66,401,129)	70,005
Shares issued in forbearance agreement																																																																															$ 166	158,183		158,349
Shares issued in forbearance agreement (in shares)																																																																															16,667
Balance (in shares) at Dec. 31, 2018																																																																												79,246			1,409,175
Balance at Dec. 31, 2018																																																																												$ 792			$ 14,092	63,146,533	(63,107,945)	53,472
Net loss																																																																																		(1,828,080)
Balance (in shares) at Jun. 30, 2019																																																																												79,246	3,500,000	84	3,097,476
Balance at Jun. 30, 2019																																																																												$ 792	$ 35,000	$ 1	$ 30,975	87,160,845	(64,936,025)	22,291,588
Balance (in shares) at Mar. 31, 2019																																																																												79,246			1,736,015
Balance at Mar. 31, 2019																																																																												$ 792			$ 17,360	66,452,982	(66,401,129)	70,005
Warrants issued pursuant to 2020 convertible debt																																					$ 23,550		$ 23,550					$ 117,241		$ 117,241																																		6,261,591		6,261,591
Shares issued pursuant to note conversions - bridge loan																													$ 399	148,173		148,572
Shares issued pursuant to note conversions - bridge loan (in shares)																													39,873
Vesting expense																																																																																1,380,620		1,380,620
Net loss																																																																																	1,465,104	1,465,104
Exercise of warrants and issuance of new warrant																																																																															$ 579	5,207		5,786
Exercise of warrants and issuance of new warrant (in shares)																																																																															57,856
Balance (in shares) at Jun. 30, 2019																																																																												79,246	3,500,000	84	3,097,476
Balance at Jun. 30, 2019																																																																												$ 792	$ 35,000	$ 1	$ 30,975	87,160,845	(64,936,025)	22,291,588
Stock issued to extinguish debt as part of Helomics purchase consideration																																																																															$ 8,637	6,454,672		6,463,309
Stock issued to extinguish debt as part of Helomics purchase consideration (in shares)																																																																															863,732
Stock issued for Helomics acquisition (in shares)																																																																													3,500,000		400,000
Stock issued for Helomics acquisition																																																																													$ 35,000		$ 4,000	5,573,250		5,612,250
Issuance of Series E Preferred shares																																																																														$ 1		743,559		743,560
Issuance of Series E Preferred shares (in shares)																																																																														84
Balance (in shares) at Dec. 31, 2019																																																																												79,246	3,500,000	258	4,056,652
Balance at Dec. 31, 2019																																																																												$ 792	$ 35,000	$ 3	$ 40,567	93,653,667	(82,498,711)	11,231,318
Shares issued pursuant to CEO exchange agreement																																																																															$ 500	129,500		130,000
Shares issued pursuant to CEO exchange agreement (in shares)																																																																															50,000
Inducement shares issued pursuant to promissory note extension																																																																															$ 300	40,950		41,250
Inducement shares issued pursuant to promissory note extension (in shares)																																																																															30,000
Issuance of shares and prefunded warrants pursuant to March 2020 private placement																																																																															$ 2,600	455,223		457,823
Issuance of shares and prefunded warrants pursuant to March 2020 private placement (in shares)																																																																															260,000
Inducement shares issued pursuant to 2020 convertible debt and warrants																																																																															$ 468	119,532		120,000
Inducement shares issued pursuant to 2020 convertible debt and warrants (in shares)																																																																															46,875
Warrants issued pursuant to 2020 convertible debt																																																																																116,951		116,951
Shares issued pursuant to note conversions - bridge loan																													$ 1,700	$ 265,628		$ 267,328																																														$ (1)	$ 1,412	(1,411)
Shares issued pursuant to note conversions - bridge loan (in shares)																													170,000																																																	(50)	141,191
Shares issued pursuant to Equity Line (in shares)																																																																															943,000
Shares issued pursuant to Equity Line																																																																															$ 9,430	1,860,469		1,869,899
Shares issued to consultant and other																																																																															$ 1,550	360,750		362,300
Shares issued to consultant and other (in shares)																																																																															155,000
Vesting expense																																																																																287,838		287,838
Net loss																																																																																	(4,529,317)	(4,529,317)
Balance (in shares) at Mar. 31, 2020																																																																												79,246	3,500,000	208	5,852,718
Balance at Mar. 31, 2020																																																																												$ 792	$ 35,000	$ 2	$ 58,527	97,289,097	(87,028,028)	10,355,390
Balance (in shares) at Dec. 31, 2019																																																																												79,246	3,500,000	258	4,056,652
Balance at Dec. 31, 2019																																																																												$ 792	$ 35,000	$ 3	$ 40,567	93,653,667	(82,498,711)	11,231,318
Net loss																																																																																		(8,106,695)
Balance (in shares) at Jun. 30, 2020																																																																												79,246			13,190,787
Balance at Jun. 30, 2020																																																																												$ 792			$ 131,908	102,163,864	(90,605,406)	11,691,158
Balance (in shares) at Mar. 31, 2020																																																																												79,246	3,500,000	208	5,852,718
Balance at Mar. 31, 2020																																																																												$ 792	$ 35,000	$ 2	$ 58,527	97,289,097	(87,028,028)	10,355,390
Shares issued pursuant to CEO exchange agreement																$ 13,968	$ 591,949		$ 605,917
Shares issued pursuant to CEO exchange agreement (in shares)																1,396,826
Issuance of shares and prefunded warrants pursuant to March 2020 private placement																																																		$ 13,902	$ (13,148)		$ 754
Warrants issued pursuant to 2020 convertible debt																																																																																62,373		62,373
Shares issued pursuant to note conversions - bridge loan																																																								$ (2)	$ 12,574	$ (12,572)				$ (35,000)		$ 3,500	$ 31,500
Shares issued pursuant to note conversions - bridge loan (in shares)																																																								(208)	1,257,416
Vesting expense																																																																																134,939		134,939
Net loss																																																																																	(3,577,378)	(3,577,378)
Shares issued pursuant to CEO note conversion and accrued interest and exchange agreement																																																																															$ 15,335	2,177,543		2,192,878
Shares issued pursuant to CEO note conversion and accrued interest and exchange agreement (in shares)																																																		1,390,166																													1,533,481
Shares issued pursuant to series D preferred stock conversions (in shares)																																																														(3,500,000)		350,004
Shares issued in connection with Asset Purchase Agreement																						$ 1,150	$ 185,150		$ 186,300
Shares issued in connection with Asset Purchase Agreement (in shares)																						115,000
Exercise of warrants and issuance of new warrant																																																																															$ 12,748	1,682,237		1,694,985
Exercise of warrants and issuance of new warrant (in shares)																																																																															1,274,826
Director compensation																																																																								$ 204	$ 34,796		$ 35,000
Director compensation (in shares)																																																																								20,350
Balance (in shares) at Jun. 30, 2020																																																																												79,246			13,190,787
Balance at Jun. 30, 2020																																																																												$ 792			$ 131,908	$ 102,163,864	$ (90,605,406)	$ 11,691,158